GK
Therapeutic Areas
SELLAS Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Galinpepimut-S (GPS) | Acute Myeloid Leukemia (AML) | Phase 3 |
| SLS009 (tambiciclib) | Relapsed/Refractory AML | Phase 2 |
| Nelipepimut-S (NPS) | Breast Cancer (HER2/neu+) | Phase 2b |
Leadership Team at SELLAS Life Sciences
JP
Javier Pinilla-Ibarz, M.D., Ph.D.
Scientific Advisory Board Member
SN
Sattva Neelapu, M.D., Ph.D.
Scientific Advisory Board Member
LW
Linghua Wang, M.D., Ph.D.
Scientific Advisory Board Member
LW
Larry W. Kwak, M.D., Ph.D.
Scientific Advisory Board Member
AK
Alex Kentsis, M.D., Ph.D.
Scientific Advisory Board Member